“Targeting Interleukin-6 Signaling with Tocilizumab in Atherosclerosis: A Meta-Analysis of Anti-Inflammatory Effects and Plaque Stabilization”, OAIJMR, vol. 5, no. 1, pp. 1–14, Jan. 2025, doi: 10.37275/oaijmr.v5i1.686.